Nourishing Success: A Definitive Guide to Lab Animals Diets
Importance of Lab Animal Diet in Research A well-formulated lab animal diet is essential for maintaining the health and well-being of laboratory animals, which ultimately affects the quality and reliability of experimental results. Researchers need to ensure that the diets of their test subjects are balanced, consistent, and free from harmful substances to limit potential […]
The Preclinical Puzzle: How Models Unlock Disease Mysteries
In the realm of medical research, preclinical studies serve as the vital gateway to understanding diseases and developing effective treatments. Central to this process is the strategic selection and utilization of appropriate disease models. In this article, we embark on an illuminating journey, delving into the diverse preclinical models available for studying specific diseases, including […]
Healing with Genes: Understanding the Science and Ethics of Gene Therapy
How Gene Therapy Works Gene therapy involves modifying a patient’s own cells to treat or cure a disease. This is done by introducing a new or modified gene into the patient’s cells, which can correct a genetic defect or produce a therapeutic protein. There are two main types of gene therapy: somatic gene therapy and […]
The National Medical Devices Policy 2023: Everything you need to know
The National Medical Devices Policy, 2023 has been approved by the Union Cabinet, chaired by PM Modi, to tap the potential of the sector and facilitate an orderly growth of the medical device sector to meet the public health objectives of access, affordability, quality, and innovation. Are you aware of the current scenario of the […]
MuScreen™️: Revolutionizing Immunotherapy Development with In Vivo Screening
The search for effective cancer treatments is a never-ending battle that demands the most innovative and efficient solutions. Immunotherapy has emerged as a promising approach to combat cancer, but its complex nature and unpredictable outcomes have made it a difficult field to navigate. Unfortunately, most immunotherapy agents are not effective for 60 to 70% of […]
Breaking Boundaries: The Promise of iPSCs in Biomedical Applications
Induced pluripotent stem cells (iPSCs) have revolutionized the field of biomedical research and are a promising therapeutic tool for treating a wide range of diseases. iPSCs are adult cells that have been reprogrammed to behave like embryonic stem cells, which can differentiate into any type of cell in the body. These cells can differentiate into […]
Accelerating Oncology Research in the Indian Biopharma Industry with OmniScreen™ Technology
OmniScreen™ is a high throughput screening service for multiple oncology drug compounds in a single-go (lead compounds) across a diverse set of cancer cell-lines. It is your best shot to assess the early efficacy and potency of your oncology drug candidates by running initial screens with large-scale cancer cell line panels saving you cost and […]
Latest Technologies Shaping the World of Drug Discovery and Development
The pharmaceutical industry is undergoing a paradigm shift, leveraging cutting-edge technologies to expedite the drug discovery and development process. This transformation has opened up new opportunities to improve healthcare outcomes, reduce healthcare costs, and create novel therapeutics that address unmet medical needs. The following are some of the latest technologies that are revolutionizing drug discovery […]
Revolutionizing Drug Discovery and Toxicity Testing with iPSC Technology: An Overview and Potential Impact
Human-induced pluripotent stem cell (iPSC) technology has revolutionized the field of drug discovery and toxicity testing. iPSCs are generated from adult somatic cells, such as skin or blood cells, by reprogramming them to a pluripotent state similar to that of embryonic stem cells. These iPSCs can then be differentiated into various cell types, including cardiomyocytes, […]
Pre-Clinical Testing Methods
Testing the biological activity of pharmaceutical drugs, agro-chemicals and other xenobiotics on human relevant systems has increasingly become an important regulatory requirement to make a go or no-go decision (drug selection and risk assessment) before proceeding to a clinical trial. In an API industry, out of the 100% compounds that reach the pre-clinical stage, only […]
